All News

KOL Views Results: Masitinib has breakthrough potential in progressive MS but many questions remain, says leading neurologist
Ref: KOL Views Desk
Tags: KOL Views ResultsAB Science RocheMultiple Sclerosis FDA EMAClinical Research (R&D) Marketing & Sales Medical Affairs Regulatory Affairsmasitinib Ocrevus
Can Umbilical Cord Blood Infusions Benefit Children With Autism?
Tags: Conference Dispatch
Esperion Announces FDA Approval of the NEXLIZET (bempedoic acid and ezetimibe) Tablet, an Oral, Once-Daily, Non-Statin LDL-Cholesterol Lowering Medicine
Ref: GlobeNewswire
Tags: Press ReleaseEsperionDyslipidemia FDAMarketing & Sales Regulatory AffairsNexlizet
Mesoblast Reports Financial Results and Corporate Highlights for First Half Ended December 31, 2019
Ref: GlobeNewswire
Tags: Press ReleaseMesoblast Corporate AffairsRevascor Ryoncil
Y-mAbs Announces Positive Pre-BLA Meeting with FDA for Omburtamab
Ref: GlobeNewswire
Tags: Press ReleaseY-mAbs Therapeutics FDARegulatory Affairsomburtamab
Gilead announces two more COVID-19 trials testing experimental antiviral remdesivir
Ref: Business Wire, Investing.com, The Wall Street Journal, MarketWatch, Yahoo!News, Financial Post
Tags: Top StoryGileadCOVID-19 Clinical Research (R&D)Remdesivir
Numerous Presentations to Showcase Long-Term Efficacy & Safety of Glaukos Technologies at 2020 American Glaucoma Society Meeting
Ref: Business Wire
Tags: Press ReleaseGlaukosGlaucoma Clinical Research (R&D) Medical AffairsAGStravoprost
Akorn Provides Fourth Quarter and Full Year 2019 Results
Ref: GlobeNewswire
Tags: Press ReleaseAkorn Corporate Affairs
Eidos Therapeutics Reports Fourth Quarter and Year-End 2019 Financial Results and Business Update
Ref: GlobeNewswire
Tags: Press ReleaseEidos Therapeutics Corporate AffairsAG10
Ironwood Pharmaceuticals Announces Publication of Positive IW-3718 Phase IIb Data in Gastroenterology
Ref: Business Wire
Tags: Press ReleaseAssertio Therapeutics IronwoodEsophagitis-GERD Clinical Research (R&D) Medical AffairsIW-3718